Cargando…

Melatonin partially protects 661W cells from H(2)O(2)-induced death by inhibiting Fas/FasL-caspase-3

PURPOSE: Previous studies have shown that melatonin (MEL) signaling is involved in the modulation of photoreceptor viability during aging. Recent work by our laboratory suggested that MEL may protect cones by modulating the Fas/FasL-caspase-3 pathway. In this study, we first investigated the presenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Bretaño, Aída, Baba, Kenkichi, Janjua, Uzair, Piano, Ilaria, Gargini, Claudia, Tosini, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723148/
https://www.ncbi.nlm.nih.gov/pubmed/29259391
_version_ 1783285159016005632
author Sánchez-Bretaño, Aída
Baba, Kenkichi
Janjua, Uzair
Piano, Ilaria
Gargini, Claudia
Tosini, Gianluca
author_facet Sánchez-Bretaño, Aída
Baba, Kenkichi
Janjua, Uzair
Piano, Ilaria
Gargini, Claudia
Tosini, Gianluca
author_sort Sánchez-Bretaño, Aída
collection PubMed
description PURPOSE: Previous studies have shown that melatonin (MEL) signaling is involved in the modulation of photoreceptor viability during aging. Recent work by our laboratory suggested that MEL may protect cones by modulating the Fas/FasL-caspase-3 pathway. In this study, we first investigated the presence of MEL receptors (MT(1) and MT(2)) in 661W cells, then whether MEL can prevent H(2)O(2)-induced cell death, and last, through which pathway MEL confers protection. METHODS: The mRNA and proteins of the MEL receptors were detected with quantitative PCR (q-PCR) and immunocytochemistry, respectively. To test the protective effect of MEL, 661W cells were treated with H(2)O(2) for 2 h in the presence or absence of MEL, a MEL agonist, and an antagonist. To study the pathways involved in H(2)O(2)–mediated cell death, a Fas/FasL antagonist was used before the exposure to H(2)O(2). Finally, Fas/FasL and caspase-3 mRNA was analyzed with q–PCR and immunocytochemistry in cells treated with H(2)O(2) and/or MEL. Cell viability was analyzed by using Trypan Blue. RESULTS: Both MEL receptors (MT(1) and MT(2)) were detected at the mRNA and protein levels in 661W cells. MEL partially prevented H(2)O(2)-mediated cell death (20–25%). This effect was replicated with IIK7 (a melatonin receptor agonist) when used at a concentration of 1 µM. Preincubation with luzindole (a melatonin receptor antagonist) blocked MEL protection. Kp7–6, an antagonist of Fas/FasL, blocked cell death caused by H(2)O(2) similarly to what was observed for MEL. Fas, FasL, and caspase-3 expression was increased in cells treated with H(2)O(2), and this effect was prevented by MEL. Finally, MEL treatment partially prevented the activation of caspase-3 caused by H(2)O(2). CONCLUSIONS: The results demonstrate that MEL receptors are present and functional in 661W cells. MEL can prevent photoreceptor cell death induced by H(2)O(2) via the inhibition of the proapoptotic pathway Fas/FasL-caspase-3.
format Online
Article
Text
id pubmed-5723148
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-57231482017-12-19 Melatonin partially protects 661W cells from H(2)O(2)-induced death by inhibiting Fas/FasL-caspase-3 Sánchez-Bretaño, Aída Baba, Kenkichi Janjua, Uzair Piano, Ilaria Gargini, Claudia Tosini, Gianluca Mol Vis Research Article PURPOSE: Previous studies have shown that melatonin (MEL) signaling is involved in the modulation of photoreceptor viability during aging. Recent work by our laboratory suggested that MEL may protect cones by modulating the Fas/FasL-caspase-3 pathway. In this study, we first investigated the presence of MEL receptors (MT(1) and MT(2)) in 661W cells, then whether MEL can prevent H(2)O(2)-induced cell death, and last, through which pathway MEL confers protection. METHODS: The mRNA and proteins of the MEL receptors were detected with quantitative PCR (q-PCR) and immunocytochemistry, respectively. To test the protective effect of MEL, 661W cells were treated with H(2)O(2) for 2 h in the presence or absence of MEL, a MEL agonist, and an antagonist. To study the pathways involved in H(2)O(2)–mediated cell death, a Fas/FasL antagonist was used before the exposure to H(2)O(2). Finally, Fas/FasL and caspase-3 mRNA was analyzed with q–PCR and immunocytochemistry in cells treated with H(2)O(2) and/or MEL. Cell viability was analyzed by using Trypan Blue. RESULTS: Both MEL receptors (MT(1) and MT(2)) were detected at the mRNA and protein levels in 661W cells. MEL partially prevented H(2)O(2)-mediated cell death (20–25%). This effect was replicated with IIK7 (a melatonin receptor agonist) when used at a concentration of 1 µM. Preincubation with luzindole (a melatonin receptor antagonist) blocked MEL protection. Kp7–6, an antagonist of Fas/FasL, blocked cell death caused by H(2)O(2) similarly to what was observed for MEL. Fas, FasL, and caspase-3 expression was increased in cells treated with H(2)O(2), and this effect was prevented by MEL. Finally, MEL treatment partially prevented the activation of caspase-3 caused by H(2)O(2). CONCLUSIONS: The results demonstrate that MEL receptors are present and functional in 661W cells. MEL can prevent photoreceptor cell death induced by H(2)O(2) via the inhibition of the proapoptotic pathway Fas/FasL-caspase-3. Molecular Vision 2017-12-03 /pmc/articles/PMC5723148/ /pubmed/29259391 Text en Copyright © 2017 Molecular Vision. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed.
spellingShingle Research Article
Sánchez-Bretaño, Aída
Baba, Kenkichi
Janjua, Uzair
Piano, Ilaria
Gargini, Claudia
Tosini, Gianluca
Melatonin partially protects 661W cells from H(2)O(2)-induced death by inhibiting Fas/FasL-caspase-3
title Melatonin partially protects 661W cells from H(2)O(2)-induced death by inhibiting Fas/FasL-caspase-3
title_full Melatonin partially protects 661W cells from H(2)O(2)-induced death by inhibiting Fas/FasL-caspase-3
title_fullStr Melatonin partially protects 661W cells from H(2)O(2)-induced death by inhibiting Fas/FasL-caspase-3
title_full_unstemmed Melatonin partially protects 661W cells from H(2)O(2)-induced death by inhibiting Fas/FasL-caspase-3
title_short Melatonin partially protects 661W cells from H(2)O(2)-induced death by inhibiting Fas/FasL-caspase-3
title_sort melatonin partially protects 661w cells from h(2)o(2)-induced death by inhibiting fas/fasl-caspase-3
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723148/
https://www.ncbi.nlm.nih.gov/pubmed/29259391
work_keys_str_mv AT sanchezbretanoaida melatoninpartiallyprotects661wcellsfromh2o2induceddeathbyinhibitingfasfaslcaspase3
AT babakenkichi melatoninpartiallyprotects661wcellsfromh2o2induceddeathbyinhibitingfasfaslcaspase3
AT janjuauzair melatoninpartiallyprotects661wcellsfromh2o2induceddeathbyinhibitingfasfaslcaspase3
AT pianoilaria melatoninpartiallyprotects661wcellsfromh2o2induceddeathbyinhibitingfasfaslcaspase3
AT garginiclaudia melatoninpartiallyprotects661wcellsfromh2o2induceddeathbyinhibitingfasfaslcaspase3
AT tosinigianluca melatoninpartiallyprotects661wcellsfromh2o2induceddeathbyinhibitingfasfaslcaspase3